Curemark Enrolls First Patients In Phase III Clinical Trials For Autism Treatment
Links shared publicly online about this topic.
- 1,675total visits
Curemark Enrolls First Patients In Phase III Clinical Trials For Autism Treatment
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its aut
View full resource at medicalnewstoday.com
Tags: Neurology, Autism Spectrum Disorder, Autism, Disease and Condition, Drug, Clinical Trial
Most Recently Shared on October 15, 2009 at 12:55 pm By:
Curemark Enrolls First Patients In Phase III Clinical Trials For Autism Treatment: Curemark, LLC, a drug resear.. http://bit.ly/JjwMF
Also Shared By:
Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites
medicalnewstoday.com — “Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 1:22 pm By:
MNT Clinical Trials Health News
Curemark Opens Patient Enrollment For Autism Treatment At Three More Clinical Trial Sites: Curemark LLC, a drug.. http://bit.ly/VLv9F
Advertisement
MNT Neurology News
@mnt_neurology
Curemark Enrolls First Patients In Phase III Clinical Trials For Autism Treatment: Curemark, LLC, a drug resear.. http://bit.ly/JjwMF
1 year ago...